van Elsas Andrea 4
4 · ADURO BIOTECH, INC. · Filed Sep 14, 2018
Insider Transaction Report
Form 4
van Elsas Andrea
Chief Scientific Officer
Transactions
- Sale
Common Stock
2018-09-13$6.50/sh−9,754$63,394→ 264,286 total - Award
Common Stock
2018-09-12+67,825→ 274,040 total
Footnotes (3)
- [F1]Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2018.
- [F2]The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.